Wenzhou Haihe Pharmaceutical Co., Ltd.

Wenzhou Haihe Pharmaceutical is a Chinese pharmaceutical company established in Zhejiang province in 2001. It develops, manufactures, and markets both traditional Chinese herbal medicines and chemical drug generics. The company has received approval for at least one product—Ganlu Detoxification Pill—for cholecystitis, and has been involved in high-profile patent linkage litigation regarding its application to market a generic version of Eldecalcitol/Aidecalcidol Soft Capsule for osteoporosis. The Beijing IP Court ruled that their generic did not infringe the relevant patent, allowing potential market entry upon regulatory approval.